hydrochlorothiazide NDC 62332-070

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-070Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0070Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-070-10	62332007010	10 BLISTER PACK in 1 CARTON (62332-070-10) / 10 CAPSULE in 1 BLISTER PACKMarketed from Mar 2, 2017
62332-070-30	62332007030	30 CAPSULE in 1 BOTTLE (62332-070-30)Marketed from Mar 2, 2017
62332-070-31	62332007031	100 CAPSULE in 1 BOTTLE (62332-070-31)Marketed from Mar 2, 2017
62332-070-71	62332007071	500 CAPSULE in 1 BOTTLE (62332-070-71)Marketed from Mar 2, 2017
62332-070-91	62332007091	1000 CAPSULE in 1 BOTTLE (62332-070-91)Marketed from Mar 2, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200645
Marketing start: Mar 2, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 62332-070_b3a6e9ad-418d-420f-bb45-9c1bc8df2337SPL ID b3a6e9ad-418d-420f-bb45-9c1bc8df2337SPL set ID 841b7962-bf5d-4c45-b594-80b17ba5187dRxCUI 199903UNII 0J48LPH2THUPC 0362332070305
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332007010 followed by a unit qualifier and the quantity

Package 62332-0070-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 11, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrochlorothiazide capsules, USP are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxem…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200645

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200645
Product	Strength	Form · route	Labeler	Product NDC
hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-438